355 related articles for article (PubMed ID: 15156181)
21. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
[TBL] [Abstract][Full Text] [Related]
22. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
23. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
Tsuzuki S; Seto M; Greaves M; Enver T
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
[TBL] [Abstract][Full Text] [Related]
24. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
[TBL] [Abstract][Full Text] [Related]
25. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
26. Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions.
Gamerdinger U; Teigler-Schlegel A; Pils S; Bruch J; Viehmann S; Keller M; Jauch A; Harbott J
Genes Chromosomes Cancer; 2003 Mar; 36(3):261-72. PubMed ID: 12557226
[TBL] [Abstract][Full Text] [Related]
27. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia.
Farra C; Awwad J; Valent A; Lozach F; Bernheim A
Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8.
Matsushita H; Kizaki M; Kobayashi H; Muto A; Ikeda Y
Br J Cancer; 1999 Mar; 79(9-10):1325-31. PubMed ID: 10188872
[TBL] [Abstract][Full Text] [Related]
29. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
Wang YY; Zhou GB; Yin T; Chen B; Shi JY; Liang WX; Jin XL; You JH; Yang G; Shen ZX; Chen J; Xiong SM; Chen GQ; Xu F; Liu YW; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1104-9. PubMed ID: 15650049
[TBL] [Abstract][Full Text] [Related]
30. The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation.
Peterson LF; Wang Y; Lo MC; Yan M; Kanbe E; Zhang DE
Leukemia; 2007 Sep; 21(9):2010-9. PubMed ID: 17657222
[TBL] [Abstract][Full Text] [Related]
31. Transformation properties of the ETO gene, fusion partner in t(8:21) leukemias.
Wang J; Wang M; Liu JM
Cancer Res; 1997 Jul; 57(14):2951-5. PubMed ID: 9230207
[TBL] [Abstract][Full Text] [Related]
32. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
Sakai I; Tamura T; Narumi H; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
[No Abstract] [Full Text] [Related]
34. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO.
Kuchenbauer F; Schnittger S; Look T; Gilliland G; Tenen D; Haferlach T; Hiddemann W; Buske C; Schoch C
Br J Haematol; 2006 Sep; 134(6):616-9. PubMed ID: 16938118
[TBL] [Abstract][Full Text] [Related]
35. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.
Yuan Y; Zhou L; Miyamoto T; Iwasaki H; Harakawa N; Hetherington CJ; Burel SA; Lagasse E; Weissman IL; Akashi K; Zhang DE
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10398-403. PubMed ID: 11526243
[TBL] [Abstract][Full Text] [Related]
36. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
[TBL] [Abstract][Full Text] [Related]
37. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G
Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517
[TBL] [Abstract][Full Text] [Related]
38. Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
Buonamici S; Ottaviani E; Visani G; Bonifazi F; Fiacchini M; Baccarani M; Martinelli G
Haematologica; 2004 Jan; 89(1):103-5. PubMed ID: 14754613
[No Abstract] [Full Text] [Related]
39. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y
Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586
[TBL] [Abstract][Full Text] [Related]
40. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]